TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.

Brian M Wolpin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.